Billionaire Profile
Cyrus Poonawalla
Global Rank
#88

Image: Amarjeetkumarcompaniespride1 | CC BY-SA 4.0 | via Wikimedia Commons

Cyrus Poonawalla

CEO, Vaccines
INDIA
Real-Time Net Worth
$26.533B
Estimated based on Vaccines stock value as of March 6, 2026
+0.06% (24h)
Age
84
Source
Vaccines
Industry
Healthcare
Citizenship
INDIA

Biography

Cyrus S. Poonawalla, born in 1941, is an Indian billionaire businessman, celebrated for founding the Serum Institute of India in 1966. He is the chairman of the Cyrus Poonawalla Group, which has diversified interests including financial services. Poonawalla is widely recognized as the "Vaccine King" for building the world's largest vaccine manufacturer by doses, producing over 1.5 billion doses annually. His career began in the horse racing and breeding business, but he shifted focus to healthcare, creating a business model that made life-saving vaccines affordable to the poor. As of February 2, 2026, his net worth is estimated at $18.7 Billion. Poonawalla is known for his philanthropy and has received multiple awards for his contributions to the pharmaceutical industry and public health.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

Cyrus Soli Poonawalla was born into a Parsi family in Pune, Maharashtra, India, on May 11, 1941. His father, Soli Poonawalla, was a horse breeder, and the family owned the Poonawalla Stud Farms, which instilled an early exposure to business and entrepreneurship. He attended The Bishop's School in Pune and later studied at Brihan Maharashtra College of Commerce (BMCC) in Pune.

Rise to Success

Poonawalla founded the Serum Institute of India in 1966. Initially, the company developed vaccines for diseases like diphtheria, tetanus, and scarlet fever using horse serum. The company's major breakthrough came in the 1980s when it received accreditation to supply vaccines to UN agencies. Under his leadership, the Serum Institute of India has become the world's largest vaccine manufacturer by the number of doses produced, supplying vaccines to over 140 countries and producing over 1.5 billion doses annually.

Key Business Strategies

Poonawalla's business strategy focused on keeping vaccine prices low to gain a greater share of the market, making life-saving vaccines affordable. He also expanded the company's portfolio to include vaccines for various diseases, including measles, polio, and flu. Poonawalla invested in new factories and technologies, including during the COVID-19 pandemic, when the Serum Institute invested $800 million to build a new factory to manufacture COVID-19 vaccines.

Philanthropy

Cyrus Poonawalla is also known for his philanthropic activities, with a focus on education, healthcare, and animal welfare. He founded the Villoo Poonawalla Charitable Foundation in 2012 in memory of his late wife, Villoo Poonawalla, which focuses on enhancing lives through education, healthcare, water and environment sanitation, and green spaces. In May 2019, he and Naum Koen proposed supplying Ukraine with 100,000 doses of measles vaccines for free vaccination.

Career Milestones

1966

Founded Serum Institute of India

Established the Serum Institute of India to manufacture vaccines.

1980s

Accreditation by UN Agencies

Received accreditation to supply vaccines to agencies of the United Nations, which boosted sales.

2005

Padma Shri

Awarded Padma Shri for his contribution to the field of medicine.

2022

Padma Bhushan

Received Padma Bhushan for contributions in vaccine production during the COVID-19 pandemic.

Philanthropy & Social Impact

Healthcare

Measles Vaccine Donation to Ukraine

Undisclosed

Proposed supplying 100,000 doses of measles vaccine to Ukraine for free vaccination

Education

Science Museum Donation

$13M

Donated to the UK's Science Museum to transform the 'Making of the Modern World' gallery into the 'Ages of Invention: The Serum Institute Gallery.'

Business Philosophy & Leadership

Notable Quotes

"We reach more children than Coca-Cola and PepsiCo can ever hope to."

Controversies & Challenges

2023

Dispute over Mumbai Mansion

Faced an eight-year delay to move into his Mumbai mansion due to ownership claims between Maharashtra and the defense ministry.

2024

Pune University Project Controversy

The Cyrus Poonawalla Group decided to pull out of a project on the Savitribai Phule Pune University (SPPU) campus following protests against the proposal.